Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
EVE Health Group Limited ( (AU:EVE) ) has issued an update.
EVE Health Group Limited has announced that its next Annual General Meeting (AGM) will be held on or about November 6, 2025, with the re-election of directors as a key agenda item. The deadline for director nominations is set for September 18, 2025. This announcement is crucial for stakeholders as it outlines the timeline for potential changes in the company’s leadership, which could impact its strategic direction and operations.
More about EVE Health Group Limited
EVE Health Group (ASX: EVE) is an Australian-based health company focused on developing and commercializing evidence-based wellness and pharmaceutical products. Through its subsidiaries Meluka Australia and Nextract, EVE delivers science-led innovations to support consumer and practitioner health across retail, pharmacy, and clinical channels.
Average Trading Volume: 403,788
Technical Sentiment Signal: Sell
Current Market Cap: A$7.14M
For detailed information about EVE stock, go to TipRanks’ Stock Analysis page.